# Why Some Heavy Cannabis Users Can’t Stop Throwing Up, According to New Research > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabinoid-hyperemesis-syndrome-pathophysiology-heavy-users/ > **Published:** 2026-04-17T15:00:22-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:19:44-04:00 > **Clinical Summary:** Explore cannabinoid hyperemesis syndrome pathophysiology in heavy cannabis users and understand diagnosis challenges and treatment through cessation. --- ✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchSafetyTHCNeurology Why This Matters Clinicians need to recognize cannabinoid hyperemesis syndrome (CHS) as a legitimate diagnosis in heavy cannabis users presenting with intractable nausea and vomiting, as the syndrome can be misdiagnosed and unnecessarily investigated when the underlying cause is not identified. This research helps providers counsel patients about dose-dependent adverse effects and establish clear cessation guidelines, since CHS resolves only with cannabis discontinuation and current standard treatments like antiemetics are ineffective. Understanding the neurobiological mechanisms of CHS enables clinicians to educate patients about individual vulnerability factors and help them make informed decisions about cannabis use frequency and potency. Clinical Summary # Clinical Summary Cannabinoid hyperemesis syndrome (CHS) represents an understudied but clinically important adverse effect in chronic heavy cannabis users, characterized by severe, cyclic vomiting that paradoxically improves with hot showers and cessation of use. Recent research enabled by [cannabis legalization](https://cedclinic.com/the-forgotten-history-of-hemp-in-america/) is now providing mechanistic insights into CHS, revealing dysregulation of endocannabinoid signaling and potential involvement of TRPV1 receptors in the gastrointestinal tract, which may explain why standard antiemetics often fail in affected patients. This growing body of evidence suggests CHS is more prevalent than previously recognized and may be underdiagnosed in clinical practice due to lack of provider awareness and the continued stigma surrounding cannabis use. Clinicians should maintain heightened suspicion for CHS in patients presenting with intractable nausea and vomiting, particularly those with heavy cannabis use histories, as cannabis cessation remains the only definitive treatment despite patient reluctance. The practical takeaway for clinicians is to screen heavy cannabis users for cyclic vomiting patterns and consider CHS in the differential diagnosis of unexplained hyperemesis, while counseling patients that discontinuation of cannabis use is necessary to achieve symptom resolution. Dr. Caplan’s Take “Cannabinoid hyperemesis syndrome is clinically real and we’re seeing it more frequently now that patients feel comfortable disclosing their heavy use, but the pathophysiology still isn’t fully understood because we spent so many years unable to do proper research on this plant. What I tell my patients is that if cannabis use is triggering cycles of vomiting that resolve only with hot showers, that’s your body telling you the risk-benefit calculation has shifted, and we need to have an honest conversation about stopping or significantly reducing use rather than chasing symptom management.” Clinical Perspective Cannabinoid hyperemesis syndrome (CHS) represents an understudied paradox in [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/): despite decades of cannabis being used to manage nausea and vomiting, heavy users occasionally develop severe, intractable hyperemesis that responds only to cessation or capsaicin application. Recent research clarifying CHS pathophysiology is valuable given legalization’s expansion of high-potency products and chronic heavy use patterns, though the condition remains rare and its exact mechanistic triggers—whether related to cannabinoid receptor supersensitivity, thermoregulatory dysfunction, or individual genetic vulnerability—are still incompletely understood. Clinicians should maintain awareness of CHS as a diagnosis in patients presenting with refractory nausea and vomiting who report [chronic cannabis use](https://cedclinic.com/cannabis-tolerance-behavioral-models/), particularly those using concentrated products, since misdiagnosis commonly leads to unnecessary diagnostic workups and delayed recognition that cessation is curative. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-related-research/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Why+Some+Heavy+Cannabis+Users+Can%27t+Stop+Throwing+Up%2C+According+to+New+Research+%40drcaplan&url=https%3A%2F%2Fhightimes.com%2Fhealth%2Fchs-study-heavy-cannabis-users-cant-stop-throwing-up-new-research%2F%3Futm_source%3Drss%26utm_medium%3Drss%26utm_campaign%3Dchs-study-heavy-cannabis-users-cant-stop-throwing-up-new-research)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fhightimes.com%2Fhealth%2Fchs-study-heavy-cannabis-users-cant-stop-throwing-up-new-research%2F%3Futm_source%3Drss%26utm_medium%3Drss%26utm_campaign%3Dchs-study-heavy-cannabis-users-cant-stop-throwing-up-new-research)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Why+Some+Heavy+Cannabis+Users+Can%27t+Stop+Throwing+Up%2C+According+to+New+Research+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fhightimes.com%2Fhealth%2Fchs-study-heavy-cannabis-users-cant-stop-throwing-up-new-research%2F%3Futm_source%3Drss%26utm_medium%3Drss%26utm_campaign%3Dchs-study-heavy-cannabis-users-cant-stop-throwing-up-new-research)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) Related Articles - [Why Some Heavy Cannabis Users Can’t Stop Throwing Up, According to New Research](https://cedclinic.com/cannabinoid-hyperemesis-heavy-cannabis-vomiting/) 📰 Source: [https://hightimes.com/health/chs-study-heavy-cannabis-users-cant-stop-throwing-up-new-research/?utm_source=rss&utm_medium=rss&utm_campaign=chs-study-heavy-cannabis-users-cant-stop-throwing-up-new-research](https://hightimes.com/health/chs-study-heavy-cannabis-users-cant-stop-throwing-up-new-research/?utm_source=rss&utm_medium=rss&utm_campaign=chs-study-heavy-cannabis-users-cant-stop-throwing-up-new-research) Further Reading Evidence Watch[Cannabis Users Show Higher Testicular Androgen Levels, New Steroid Profiling Study Finds](https://cedclinic.com/steroid-profiling-cannabis-young-men-2026/) Cannabis Policy Wire[Schedules of Controlled Substances: Placement of 4-Fluoroamphetamine in Schedule I](https://cedclinic.com/4-fluoroamphetamine-schedule-i-placement/) CED Clinic BlogButterfly numbers are dropping but here are five species you may see more of [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [This syndrome linked to heavy cannabis use is often misdiagnosed](https://cedclinic.com/this-syndrome-linked-to-heavy-cannabis-use-is-often-misdiagnosed/) Learn why cannabinoid hyperemesis syndrome is frequently overlooked and how proper diagnosis can improve patient outcomes. [Read More](https://cedclinic.com/this-syndrome-linked-to-heavy-cannabis-use-is-often-misdiagnosed/) [Scientist explains 'only two methods' to stop weed smoker's horrific 'scromiting' side effect](https://cedclinic.com/scientist-explains-only-two-methods-to-stop-weed-smokers-horrific-scromiting-side-effect/) Discover the latest research on effective ways to manage severe vomiting linked to heavy cannabis use. [Explore Now](https://cedclinic.com/scientist-explains-only-two-methods-to-stop-weed-smokers-horrific-scromiting-side-effect/) [Bouts of vomiting, nausea and abdominal pain: The little-known syndrome stalking daily …](https://cedclinic.com/bouts-of-vomiting-nausea-and-abdominal-pain-the-little-known-syndrome-stalking-daily/) Understand the clinical signs and patient experiences of cannabinoid hyperemesis syndrome in chronic users. [Learn More](https://cedclinic.com/bouts-of-vomiting-nausea-and-abdominal-pain-the-little-known-syndrome-stalking-daily/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).